SPIT
F/m Emerald Special Situations ETF
SPIT selects investments based on transformational catalysts and unique situations, targeting opportunistic growth across companies of any size.

Overview

Principal Investment Strategy

F/m Emerald Special Situations ETF (SPIT) invests in companies that exhibit meaningful potential price appreciation due to idiosyncratic internal or external catalysts leading to material price dislocation. The Fund's investments include common and preferred stock, other investment companies, and depositary receipts. It may also invest in private placements, warrants, rights, and initial public offerings. Under normal market conditions, the Fund invests at least 80% of its net assets in equity securities of companies experiencing special situations ("80% Policy"). These special situation companies can include:

  • Technological Improvement: Companies benefiting from important discoveries, acquisitions, or innovations that substantially change their business.
  • Corporate Reorganization: Firms undergoing recapitalization, security exchanges, or conversion opportunities.
  • Transformational Mergers and Acquisitions: Companies involved in material acquisitions or transformational mergers.
  • Spin-offs & Divestitures: Entities experiencing spin-outs, liquidations, or distributions of cash, securities, or assets.
  • Business Model Changes: Organizations implementing significant operational or strategic transformations.
  • Management Changes: Companies with new or changed leadership driving value creation.
  • External Disruptions: Firms positioned to benefit from business or market disruptions.
  • Regulatory Changes: Companies impacted by new legislation, industry regulations, or policy oversight.
  • Litigation Resolution: Entities where favorable legal outcomes could significantly improve stock value.

What’s So Special?

The Fund will leverage Emerald’s 30+ years’ experience focusing on companies having idiosyncratic growth drivers facilitated by both internal and external catalysts.

  • Issue: Growth benchmarks have become concentrated and dominated by mega cap tech and communications names.
    • The Fund doesn’t want to mimic the holdings of most large/mega cap dominated ETFs.

  • Issue: Most large-cap ETFs have become momentum driven and company fundamentals have become less relevant.
    • We believe fundamentals are paramount and price/valuation dislocations are the core drivers of SPIT.

  • Issue: Many ETFs are highly correlated to broader markets.
    • By focusing on companies with idiosyncratic growth or valuation catalysts, we believe the Fund’s holdings should be far less correlated.

  • Issue: Many ETFs focus on some combination of a corresponding public equity benchmark, a market cap range, and a sector.
    • The fund seeks to be benchmark agnostic and able to freely invest from micro-to-mega cap.
    • The fund seeks to be sector agnostic and will not necessarily overweight tech or communication.
    • The fund aims to have the ability to invest in international equities, PIPES, warrants, etc.

Fund Facts

as of 03/13/2026
Ticker
Exchange NASDAQ
CUSIP 74933W114
Inception Date 10/06/2025
# of Holdings 47
Gross Expense Ratio 0.89%


Net Assets 23.00M
Shares Outstanding 875,261
Premium / Discount 0.06%
Market Price $26.42
NAV $26.40
Median 30-Day Spread 0.32%
30 Day SEC Yield -0.26%(as of 01/31/2026)
Special Situations refer to securities of companies experiencing unusual and possibly non-repetitive developments that may cause the security to attain higher market value independently from general market trends.

Emerald's proprietary 10-Step Research Process screens investments through thorough analysis of financials, catalysts, surveys, interviews with industry professionals, and collaborative research to identify promising transformation opportunities.

Actively Managed ETF

Emerald’s diversified boutique management approach spans institutional, sub-advisory, ETF, and mutual fund businesses, supported by deep industry relationships and long-standing consultant partnerships. The two-person portfolio management team for this ETF brings an average of 25 years of tenure at Emerald and 35 years of industry experience, with a track record of identifying differentiated opportunities across the public equity landscape.

Backed by F/m investments LLC, a leader in ETF structure and distribution, this actively managed ETF is designed to capitalize on unique valuation dislocations and company-specific catalysts across sectors, market caps, and geographies. With a flexible, benchmark-agnostic mandate, SPIT seeks to uncover compelling opportunities often overlooked by traditional, index-constrained strategies.

Subscribe for updates

Performance

NAV Historical Change

As of 03/16/2026

Quarter End Performance

as of 12/31/2025
YTD1 Month3 Months6 Months1 Year3 Year5 Year10 Year
SPIT NAV38.47%-0.56%6.96%27.82%38.47%34.91%15.98%17.48%
SPIT MKT38.46%-0.46%6.95%27.81%38.46%34.90%15.98%17.48%
as of 02/28/2026
YTD1 Month3 Months6 Months1 Year3 Year5 Year10 Year
SPIT NAV9.35%2.17%8.73%26.35%54.01%34.04%16.21%20.10%
SPIT MKT9.29%2.07%8.78%26.27%53.92%34.02%16.20%20.09%
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted. The performance data shown for periods prior to October 6, 2025 is that of the Emerald Insights Fund (the “Predecessor Fund”), due to approval of the reorganization by shareholders of the Predecessor Fund at a meeting on September 25, 2025. Returns were generated under the management of the Predecessor Fund’s investment adviser, which is the Sub-Adviser to the F/m Emerald Special Situations ETF. The Fund’s investment strategy will differ materially from that of the Predecessor Fund such that the historical performance of the Predecessor Fund is not representative of the performance investors should reasonably expect from the Fund. The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted.

Top Holdings

As of 03/16/2026
Name Symbol/Ticker Cusip Quantity Weight (%)
U.S. Bank Money Market Deposit Account 08/01/2031USBFS048AMMF0A923830.00%
Cash & OtherCash&OtherCash&Other15,3870.07%
Soleno Therapeutics IncSLNO8342033092,8650.42%
WaVe Life Sciences LtdWVEY9530810512,6250.71%
Pixelworks IncPXLW72581M40436,4050.90%
Bridgebio Pharma IncBBIO10806X1023,1680.95%
Unity Software IncU91332U10111,9081.00%
indie Semiconductor IncINDI45569U101102,2841.10%
AeroVironment IncAVAV0080731081,3151.18%
Insmed IncINSM4576693072,1321.29%
Corcept Therapeutics IncCORT2183521029,7201.35%
Robinhood Markets IncHOOD7707001024,2761.36%
Boeing Co/TheBA0970231051,5391.40%
Matthews International CorpMATW57712810113,2011.40%
Commvault Systems IncCVLT2041661024,1581.42%
ACADIA Pharmaceuticals IncACAD00422510816,2061.45%
Starbucks CorpSBUX8552441093,7291.60%
MongoDB IncMDB60937P1061,4311.61%
FTAI Aviation LtdFTAIG3730V1051,7381.67%
Golar LNG LtdGLNGG9456A1008,9671.67%
Travere Therapeutics IncTVTX89422G10713,8601.67%
MP Materials CorpMP5533681016,8121.69%
Fair Isaac CorpFICO3032501043571.75%
Mercury Systems IncMRCY5893781085,3641.81%
BWX Technologies IncBWXT05605H1002,3812.00%
Palomar Holdings IncPLMR69753M1053,9032.03%
Skyward Specialty Insurance Group IncSKWD83094010210,3602.03%
Cardinal Infrastructure Group IncCDNL14154A10216,2062.07%
InterDigital IncIDCC45867G1011,3382.08%
MasTec IncMTZ5763231091,6652.09%
Broadcom IncAVGO11135F1011,5052.10%
American Superconductor CorpAMSC03011120716,7172.24%
TransMedics Group IncTMDX89377M1094,3062.30%
Take-Two Interactive Software IncTTWO8740541092,6232.37%
Biogen IncBIIB09062X1033,0492.40%
Modine Manufacturing CoMOD6078281002,9932.44%
Kratos Defense & Security Solutions IncKTOS50077B2077,1782.72%
LivaNova PLCLIVNG5509L10111,0602.80%
Solaris Energy Infrastructure IncSEI83418M10312,7372.87%
Arlo Technologies IncARLO04206A10149,3452.90%
Nektar TherapeuticsNKTR64026830610,0003.17%
Excelerate Energy IncEE30069T10122,2043.23%
Lumentum Holdings IncLITE55024U1091,2173.28%
Guardant Health IncGH40131M1099,2743.43%
Bloom Energy CorpBE0937121075,9473.98%
TETRA Technologies IncTTI88162F105126,8944.51%
Credo Technology Group Holding LtdCRDOG2545710510,1375.16%
F/m Ultrashort Treasury Inflation-Protected Security TIPS ETFRBIL74933W21329,3556.36%
Holdings are subject to change without notice

Quarterly Distributions

Type Declaration Date Record Date Ex-Div Date Payment Date Amount ($/share)
Dividend & Capital Gain 11/12/2025 11/13/2025 11/13/2025 11/14/2025 $1.8627
Unleashing Alpha Through Strategic Innovation

Subscribe for updates

© 2026 Emerald Advisers. All rights reserved.

Glossary of Terms

Investing involves risk. Principal loss is possible. An investor should consider the investment objectives, risks, and charges and expenses of the fund carefully before investing. A prospectus, which contains this and other information about the fund, may be obtained by calling 1-800-617-0004/visiting www.emeraldetfs.com. The prospectus should be read carefully before investing.

The Fund may invest in companies listed on U.S. and Canadian exchanges that are engaged in the use of, or have exposure to, DLT and blockchain. The risks associated with DLT, including blockchain, may not be fully known at this time, including securities fraud, theft, loss, or destruction. Use of DLT and blockchain may also result in lost or delayed transactions.

Cyber Security Risk. Cyber security risk is the risk of an unauthorized breach and access to Acquiring Fund assets, Acquiring Fund or customer information, proprietary information, or operating systems.

Financial Technology Risk. The Acquiring Fund may invest in companies engaged in financial technology-related activities. Companies that are developing financial technologies to disrupt existing or displace established financial institutions generally face competition from much larger and more established firms.

Special Situations Risk. The Acquiring Fund will seek to benefit from Special Situations, such as mergers, reorganizations, or other unusual events that may create an opportunity for investment. Investments in Special Situations may not produce the intended results and can result in significant losses for the Acquiring Fund. A Special Situation may have a negative impact on the price of the issuer’s securities and fail to produce gains or produce a loss for the Acquiring Fund.

The Acquiring Fund may have exposure to securities in emerging markets. Emerging Markets are defined by the Advisors as countries that are generally considered to be emerging or developing by the World Bank, the International Finance Corporation, the International Monetary Fund, or the United Nations. Emerging market securities tend to be more volatile than securities in developed countries. Issuers in emerging markets are also subject to risks not typically associated with issuers in more developed countries. Growth stocks are typically priced higher than other stocks, in relation to earnings and other measures, because investors believe they have more growth potential.

The Acquiring Fund may invest in companies listed on foreign markets. Securities markets are generally less liquid than securities in the United States, and foreign companies may be more vulnerable to adverse issuer, market, political, or economic developments than securities of U.S. companies and governments. Investments in private placements could decrease the Acquiring Fund’s liquidity and/or prevent the Acquiring Fund from disposing of such securities at a fair price. Investments in private placements also decrease the marketability of the securities. Equity securities of companies and funds involved in Initial Public Offerings (“IPOs”) are subject to less diverse risks. IPOs involve special risks because they are less liquid and more volatile than established companies. The Acquiring Fund may invest in stocks, rights, warrants, and other securities of special purpose acquisition companies or entities with a purpose entities (collectively, “SPACs”). SPACs are often subject to extreme price volatility and speculative trading. The Acquiring Fund may also invest in distressed companies, which may not produce the intended results and may result in significant losses.

The Acquiring Fund is subject to additional risks that do not apply to conventional mutual funds, including the risks that the market price of an ETF’s shares may trade at a discount to its net asset value (“NAV”), or that an actively secondary trading market may not develop or be maintained, and that trading may be halted by the exchange on which the ETF shares are traded. Brokerage commissions will reduce returns. Shares of any ETF can be bought and sold at market price (not NAV) and are not individually redeemed from the ETF. Brokerage commissions will reduce returns.

Distributed by Quasar Distributors, LLC.

Nishit Trivedi, PHD, MBBS, MBA

Portfolio Manager & Dir. of Life Sciences Research
19 Years Experience
Dr. Trivedi is a Director - Life Sciences Research for Emerald Advisers, LLC and a Portfolio Manager of the F/m Emerald Life Sciences Innovation ETF, focusing on Biotech and Medical Device companies. Dr. Trivedi received his PhD in Pharmacology in 2005 and pursued his post-doctoral fellowship at Gittlen Cancer Foundation before joining Emerald.

He has published several research articles in leading journals in the fields of oncology and dermatology and, at the 2004 Annual AACR Conference, Dr. Trivedi was the recipient of an award from the American Association for Cancer Research and AFLAC for his research efforts on melanoma. While at Penn State College of Medicine, he received the Rite Aid Graduate Fellowship Award in Pharmacology. Dr. Trivedi received both a PhD and an MBA from Pennsylvania State University. He completed his medical internship in 1999 and received his medical degree (MBBS) from Bombay University, India.

Terry M. Smith, PHD, MBA

Portfolio Manager & Dir. of Life Sciences Research
19 Years Experience

Dr. Smith is a Director – Life Sciences Research for Emerald Advisers and a Portfolio Manager of the F/m Emerald Life Sciences Innovation ETF. He spent the Summer/Fall of 2005 as an Intern at Emerald before joining the firm in the Fall of 2006. 

Dr. Smith received his PhD in Integrative Biosciences – Molecular Toxicology at Penn State College of Medicine, in Fall 2006. He has co-authored several research abstracts and articles on ‘the molecular signaling pathways involved in hormone induced cholesterol metabolism’ for the Journal of Investigative Dermatology, as well as for the Society for Investigative Dermatology’s annual international meetings. He received his MBA from the Pennsylvania State University (2004), where he also was inducted into the Beta Gamma Sigma National Business Honor Society. Dr. Smith received his BS degree in Biology (with a minor in Chemistry) from Messiah College in 2000.

Stacey L. Sears

Portfolio Manager & Senior Vice President
31 Years Experience

Ms. Sears is Senior Vice President and a senior member of the Small Cap Portfolio Management team. She is also a Portfolio Manager of the Emerald Growth Fund and the F/m Emerald Life Sciences Innovation ETF. She works directly with the research team, interacting with team members across economic sectors and helping guide the day-to-day portfolio management decision-making process.

Ms. Sears is also responsible for portfolio risk monitoring, portfolio attribution analysis, as well as Emerald’s portfolio management-related client communications. From a research perspective, Ms. Sears maintains research coverage of the Retail, Apparel, Restaurant, Consumer Goods and Consumer Technology companies. She has appeared on CNBC, Yahoo! Finance, Schwab TV, and InvestmentNews IN the Nasdaq and has been quoted in Fortune, Money, the Dow Jones News Service and other media. Ms. Sears received a BS in Business Administration from Millersville University and an MBA from Villanova University.

Kenneth G. Mertz II, CFA

Portfolio Manager & Chief Investment Officer
47 Years Experience
Mr. Mertz is Chief Investment Officer and President of Emerald Advisers, LLC and a member of the Small Cap Portfolio Management team. He is also a Co-Manager of the Emerald Finance & Banking Innovation Fund and a Portfolio Manager of the Emerald Growth Fund and the F/m Emerald Life Sciences Innovation ETF.

Portfolio Manager, Emerald Financial Services Private Equity Fund I, LP.; past Trustee and Vice President of the Emerald Mutual Funds; Chief Investment Officer, PA State Employees’ Retirement System (1985-1992); Member, CFA Institute; past Member, Pennsylvania State University Research Foundation; past Trustee, Evangelical Lutheran Church in America Board of Pensions; past Trustee, Pennsylvania State University Endowment Council (1998-2004); and past Chair, President, & Director of Central Pennsylvania Investment Managers. He was formerly Chairman of the Diakon Board and Chairman of the Diakon Lutheran Fund, its endowment arm. Mr. Mertz has been quoted in The Wall Street Journal and in USA Today and has served as speaker at various investment seminars and programs across the country. He has been a guest on CNBC’s Mutual Fund Investor and has been interviewed several times on CNBC and Bloomberg TV. Mr. Mertz graduated from Millersville University with a BA in Economics. Mr. Mertz is a CFA charterholder.

Kenneth G. Mertz has earned the right to use the Chartered Financial Analyst designation. CFA Institute marks are trademarks owned by the CFA Institute.

Kenneth G. Mertz has earned the right to use the Chartered Financial Analyst designation. CFA Institute marks are trademarks owned by the CFA Institute.

Joseph W. Garner

Portfolio Manager & Director of Research
31 Years Experience

Mr. Garner is Director of Research and a member of the Small Cap Growth Portfolio Management team. He is also a Portfolio Manager of the Emerald Growth Fund and the F/m Emerald Life Sciences Innovation ETF. Mr. Garner’s research efforts are primarily focused on small and mid-sized firms in the Consumer Discretionary, Consumer Staples, Industrials, and Technology sectors.

He has appeared on Bloomberg Television and CNBC. He also has been quoted in Fortune, Bloomberg Business News, USA Today, Dow Jones News Service, Standard & Poor’s, MarketWatch, Investor’s Business Daily, Wall Street Journal, and other media. Mr. Garner previously served as President of the Millersville University Foundation and Chair of the Investment Committee. He currently serves on the Advisory Council for the Lombardo College of Business at Millersville University. Prior to joining Emerald in 1994, Mr. Garner was the Program Manager of the PA Economic Development Financing Authority (PEDFA) and an Economic Development Analyst with the PA Department of Commerce’s Office of Technology Development. Mr. Garner received an MBA from the Katz Graduate School of Business, University of Pittsburgh, and graduated magna cum laude with a BA in Economics from Millersville University.

Invest Now

Emerald is not affiliated with these financial service firms. Their listing should not be viewed as a recommendation or endorsement. By clicking the buttons above you are leaving the Emerald ETFs website and going to a 3rd party site. Emerald is not responsible for content on 3rd party sites.